FI871411A0 - Foerfarande och kompositioner foer identifiering av humana metastastumoerer. - Google Patents

Foerfarande och kompositioner foer identifiering av humana metastastumoerer.

Info

Publication number
FI871411A0
FI871411A0 FI871411A FI871411A FI871411A0 FI 871411 A0 FI871411 A0 FI 871411A0 FI 871411 A FI871411 A FI 871411A FI 871411 A FI871411 A FI 871411A FI 871411 A0 FI871411 A0 FI 871411A0
Authority
FI
Finland
Prior art keywords
metastastumoerer
humana
human tumor
disclosed
foerfarande och
Prior art date
Application number
FI871411A
Other languages
English (en)
Other versions
FI89806B (fi
FI871411A (fi
FI89806C (fi
Inventor
Garth L Nicolson
Susan M North
Peter A Steck
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of FI871411A0 publication Critical patent/FI871411A0/fi
Publication of FI871411A publication Critical patent/FI871411A/fi
Publication of FI89806B publication Critical patent/FI89806B/fi
Application granted granted Critical
Publication of FI89806C publication Critical patent/FI89806C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Stereophonic System (AREA)
  • Communication Control (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Air Conditioning Control Device (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI871411A 1986-04-01 1987-03-31 Foerfarande och produkter foer identifiering av humana metastastumoerer FI89806C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/846,938 US5030559A (en) 1986-04-01 1986-04-01 Methods and compositions for the identification of metastatic human tumors
US84693886 1986-04-01

Publications (4)

Publication Number Publication Date
FI871411A0 true FI871411A0 (fi) 1987-03-31
FI871411A FI871411A (fi) 1987-10-02
FI89806B FI89806B (fi) 1993-08-13
FI89806C FI89806C (fi) 1993-11-25

Family

ID=25299361

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871411A FI89806C (fi) 1986-04-01 1987-03-31 Foerfarande och produkter foer identifiering av humana metastastumoerer

Country Status (11)

Country Link
US (1) US5030559A (fi)
EP (1) EP0240341B1 (fi)
JP (1) JPH0742320B2 (fi)
AT (1) ATE105569T1 (fi)
AU (1) AU599364B2 (fi)
CA (1) CA1307478C (fi)
DE (1) DE3789781T2 (fi)
DK (1) DK162387A (fi)
ES (1) ES2051737T3 (fi)
FI (1) FI89806C (fi)
NO (1) NO175642C (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE403802B (sv) * 1972-10-10 1978-09-04 Buchegger Masch Reinigung Anordning for rengoring och avfettning av maskindelar och liknande
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5646004A (en) * 1994-08-31 1997-07-08 Activated Cell Therapy, Inc. Methods for enriching fetal cells from maternal body fluids
US5663051A (en) * 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
US5648223A (en) * 1994-08-31 1997-07-15 Activated Cell Therapy, Inc. Methods for enriching breast tumor cells
DE19530272C1 (de) * 1995-08-17 1996-11-21 Univ Eberhard Karls Antikörper 103 B2
DE19530273C1 (de) * 1995-08-17 1996-12-12 Univ Eberhard Karls Antikörper 105A5
US20020142327A1 (en) * 2000-11-28 2002-10-03 Gillis Kimberly A. Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
NZ526617A (en) * 2000-11-28 2004-09-24 Wyeth Corp Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
PL365605A1 (en) * 2000-11-28 2005-01-10 Wyeth Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US7169722B2 (en) * 2002-01-28 2007-01-30 Guardian Industries Corp. Clear glass composition with high visible transmittance
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
MX2009002576A (es) * 2006-09-08 2009-03-20 Wyeth Corp Lavado de arginina en purificacion de proteina utilizando cromatografia de afinidad.
US20090324596A1 (en) 2008-06-30 2009-12-31 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
US10745701B2 (en) 2007-06-28 2020-08-18 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
MX347611B (es) * 2011-06-19 2017-05-04 Abogen Inc Dispositivos, soluciones y metodos para recoleccion de muestras.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
IN150740B (fi) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
DE3586216T2 (de) * 1984-05-01 1992-12-10 Ciba Corning Diagnostics Corp Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.

Also Published As

Publication number Publication date
DE3789781T2 (de) 1994-11-10
US5030559A (en) 1991-07-09
ES2051737T3 (es) 1994-07-01
ATE105569T1 (de) 1994-05-15
JPS62253395A (ja) 1987-11-05
EP0240341A2 (en) 1987-10-07
EP0240341B1 (en) 1994-05-11
NO871352D0 (no) 1987-03-31
NO175642C (no) 1994-11-09
AU599364B2 (en) 1990-07-19
FI89806B (fi) 1993-08-13
EP0240341A3 (en) 1989-07-19
FI871411A (fi) 1987-10-02
DK162387A (da) 1987-10-02
AU7075387A (en) 1987-10-08
NO175642B (fi) 1994-08-01
NO871352L (no) 1987-10-02
FI89806C (fi) 1993-11-25
DE3789781D1 (de) 1994-06-16
DK162387D0 (da) 1987-03-31
JPH0742320B2 (ja) 1995-05-10
CA1307478C (en) 1992-09-15

Similar Documents

Publication Publication Date Title
FI871411A0 (fi) Foerfarande och kompositioner foer identifiering av humana metastastumoerer.
ES8609731A1 (es) Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero
EP0288082A3 (en) A tumor specific assay for ca125 ovarian cancer antigen
WO1999004265A8 (en) Cancer associated nucleic acids and polypeptides
DE3483054D1 (de) Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie.
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
ATA328286A (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
EP0163303A3 (en) Human monoclonal antibodies to cell surface and intracellular antigens
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
CA2207505A1 (en) Neurological drug screens
SE8100011L (sv) Detektering av cancerceller
AU2883597A (en) Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
DE3582191D1 (de) Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen).
WO1991017187A3 (en) A 35kd tumor associated protein antigen: uses and methods of detection
AU3350993A (en) Method for testing for the presence of metastatic tumor cells
EP0272113A3 (en) Anti-human cancer monoclonal antibodies
GR3007245T3 (fi)
AU5646980A (en) Method of diagnosing arterosclerosis
WO1987006578A3 (en) Novel flecainide derivatives and their use in immunoassays
EP0339633A3 (en) Anti-human gastric cancer monoclonal antibody
NO914094L (no) Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer
NO894332D0 (no) Fremgangsmaate for fremstilling av metanol og katalysator for denne.
IT1215416B (it) Chiusura lampo formata da nastri di supporto tessuti e da file di elementi articolati di chiusura, prefabbricati, inseriti nel tessuto.
IT8021467A0 (it) Struttura di accoppiato composito particolarmente per nastri decorativi ed elementi di rivestimento in genere, nonche'procedimento per l'ottenimento didetto accoppiato composito.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: BOARD OF REGENTS